500 patients67,039 observations150 daysLIVE

Patient P-03166

Synthetic patientONX-7 · Day 143 · 75+ · M · baseline S20Open companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Unstable
Discontinuation risk
47%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S20
  2. Day 97 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 102 CR-01 recommendedClinician Review CR-01
  4. Day 103 Patient acceptedStarted CR-01 in the companion
  5. Day 108 Deterioration detected before clinical escalationClinician Review CR-01

What changed?

Trajectory began diverging from predicted response on Day 97.

Primary contributors, last 14 days
  • Toxicity-13
  • GI instability-9
  • Inflammatory activity-9
  • Nutritional resilience+6

What helped?

  • Clinician Review CR-01Day 102
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
59%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 82% showed improvement
  • median effect visible after 8 days

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 44/100
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 75 bpm
    • WearableShort sleep window
  • Inflammatory signalling 40
    • BloodInflammatory load index 49
    • WearableHRV 33 ms, trending down
  • Mucosal barrier integrity 20
    • Daily logGI symptom score 54 and rising
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 1.8 · butyrate capacity 44/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
32 ms
Sleep
6.3 h
Steps
4,345
Resting HR
77 bpm
Daily log: GI score 54, nutritional resilience 42, adherence 72.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0338245%S01GI-04improved56
P-0320144%S15GI-04improved68
P-0309943%S17CR-01improved55
P-0322543%S19GI-04improved50
P-0346542%S17CR-01improved65
P-0319141%S19GI-04improved51
P-0303137%S16CR-01improved49
P-0309037%S02GI-04improved48
P-0314637%S14GI-04improved53
P-0307036%S14GI-04improved51
P-0312336%S14GI-04improved50
P-0335736%S02CR-01improved50